This website uses its own and third party technical cookies, solely to ensure enhanced navigation and to gather anonymous statistical navigation data without any user profiling.

If you wish to learn more or deny consent to all or some cookies click here.

If you access any element below this banner you automatically consent to the use of cookies.


  1. Galileo Research »
  2. Opportunità per Investitori »
  3. Advisor


PriceWaterhouseCoopers Corporate Finance Inc. cooperates with Galileo Research Srl on an exclusive basis to evaluate strategic partnerships both on financial or industrial perspective in order to facilitate the development of its proprietary allogeneic cell line (TALL 104) for cancer therapy.